Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model

Clinical Endocrinology

Volumn 52, Issue 6, 2000, Pages 687-694

  Zhang, Rusheng ^a   DeGroot, Leslie J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ADENOVIRUS; ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CARCINOGENICITY; CELL PROLIFERATION; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECOMBINANT DNA TECHNOLOGY; THYROID MEDULLARY CARCINOMA; TUMOR IMMUNITY; VIRUS RECOMBINANT;

ANIMALS; CARCINOMA, MEDULLARY; CELL DIVISION; CONCANAVALIN A; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERLEUKIN-12; MICE; RATS; RATS, INBRED STRAINS; SPLEEN; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034046425     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01003.x     Document Type: Article

References (34)

1. Becker, T.C., Noel, R.J., Coats, W.S., Gomez-Foix, A.M., Alam, T., Gerard, R.D. & Newgaard, C.B. (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Protein Expression in Animal Cells. Methods in Cell Biology, 43, 161-188.
2. Brumson, J., Hitt, M., Gallichan, W.S., Rosenthal, K.L.,., Gauldie, J. & Graham, F.L. (1996a) Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12. Human Gene Therapy, 7, 333-342.
3. Bramson, J.L., Hitt, M., Addison, C.L., Muller, W.J., Gauldie, J. & Graham, F.L. (1996b) Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Human Gene Therapy, 7, 1995-2002.
4. Brunda, M.J., Luistro, L., Warrier, L., Wright, R., Hubbard, B., Murphy, M., Wolf, S. & Gately, M. (1993) Anti-tumor and antimetastatic activity of IL12 against murine tumors. Journal of Experimental Medicine, 178, 1223-1230.
5. Chen, L., Chen, D., Block, E., O'Donnell, M., Kufe, D.W. & Clinton, S.K. (1997) Eradication of murine bladder carcinoma by intrtumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. Journal of Immunology, 159, 351-359.
6. Colombo, M.P., Vagliani, M., Spreafico, F., Parenza, M., Chiodoni, C., Melani, C. & Stoppacciaro, A. (1996) Amount of interleukin-12 available at the tumor site is critical for tumor regression. Cancer Research, 56, 2531-2534.
7. Davidoff, A.M., Kimbrough, S.A., Ng, C.Y.C., Shochal, S.J. & Memphis. E.F.V. (1999) Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12. Journal of Pediatrics Surgery, 34, 902-907.
8. Gately, M.K., Warrier, R.R., Honasoge, S., Carvajal, D.M., Faherty, D.A., Connaughton, S.E., Anderson, T.D., Sarmiento, U., Hubbard, B.R. & Murphy, M. (1994) Administration of recombinant IL12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. International Immunology, 6, 157-167.
9. Graham, F.L. & Van Der Eb, E.J. ( 1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
10. Graham, F.L. & Preve, C.L. (1991) Manipulation of adenovirus vectors. Gene transfer and expression protocols. In: Methods in Molecular Biology (ed. E. Murry), pp. 109-128. Humana Press, Inc., Clifton.
11. Gambott, A., Tuting, T., McVey, D.L., Kovesdi, I., Tahara, H., Lotze, M.T. & Robbins, P.D. (1999) Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Therapy, 6, 45-53.
12. Haddada, H., Ragot, T., Cordier, L., Duffour, M.T. & Perricaudet, M. (1993) Adenoviral interlcukin-2 gene transfer into p815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Human Gene Therapy, 4, 703-711.
13. Johnson, D.C., Ghosh-Choudhury, G., Smiley, J.R., Fallis, L. & Graham, F.L. (1998) Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology, 164, 1-14.
14. Lee, C.-T., Wu, S., Ciernik, F., Chen, H., Nadaf-Rahrov, S., Gabrilovich, D. & Carbone, D.P. (1997) Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor. Human Gene Therapy, 8, 187-193.
15. Marshall, E. (1995) Cancer trail of interleukin-12 halts. Science, 268, 1555.
16. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G. & Colombo, M.P. (1995) CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. European Journal of Immunology, 25, 137-146.
17. McGrory, W.J., Bautista, D.S. & Graham, F.L. (1988) A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology, 163, 614-617.
18. Mittal, S.K., Bett, A.J., Prevec, L. & Graham, F .L. (1995) Foreign gene expression by human adenovirus type 5 base vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology, 210, 226-230.
19. Nastala, C.L., Edington, H.D., Mckinney, T.G., Tahara, H., Nalesnik, M.A., Brunda, M.J. & Lotze, M.T. (1994) Recombinant 1L-12 administration induces tumor regression in association with IFN-γ production. Journal of Immunology, 153, 1697-1700.
20. Noguchi, Y., Richards, E.C., Chen, Y.-T. & Old, L.J. (1995) Influence of interleukin 12 on p53 peptide vaccination against established meth A sarcoma. Proceedings of the National Academy of Sciences of the USA, 92, 2219-2223.
21. Orange, J.S., Salazar-Mather, T.P., Opal, S.M., Spencer, R.L., Miller, A.H., McEwen, B.S. & Biron, C.A. (1995) Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. Journal of Experimental Medicine, 181, 901-914.
22. Rakhmilevich, A.L., Turner, J., Ford, A.J., McCabe, D., Sun, W.H., Sondel, P.M., Grota, K. & Yang, N.-S. (1996) Gene gun-mediated skin transfection with interleukin-12 gene results in regression of established primary and metastatic murine tumors. Proceedings of the National Academy of Sciences of the USA, 93, 6291-6296.
23. Randrianarison-Jewtoukoff, V. & Perricaudet, M. (1995) Recombinant adenoviruses as vaccines. Biologicals, 23, 145-157.
24. Roth, J. A. & Cristiano, R.J. (1997) Gene therapy for cancer: What have we done and where are we going? Journal of the National Cancer Institutes, 89, 21-39.
25. Sarmiento, U.M., Riley, J.H., Knaack, P.A., Lipman, J.M., Becker, J.M., Gately, M.K., Chizzonite, R. & Anderson, T.D. (1994) Biological effects of recombinant human interleukin-12 in squirrel monkey (Sciureus saimiri). Laboratory and Investigations, 71, 862-873.
26. Schoenhaut, D.S., Chua, A.O., Wolitzky, A.G., Quinn, P.M., Dwyer, C.M., McComas, W., Familletti, P.C., Gately, M.K. & Gubler, U. (1992) Cloning and expression of murine IL-12. The Journal of Immunology, 148, 3433-3440.
27. Siders, W.M., Wright, P.W., Hixon, J.A., Alvord, W.G., Back, T.C., Wiltrout, R.H. & Fenton, R.G. (1998) T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. Journal of Immunology, 160, 5465-5474.
28. Tahara, H., Zeh, H.J., II, McKinney, T.G., Schreiber, R.D., Gubler, U., Stokus, W.J.. Pappo. I., Watkins, S.C., Gubler, U., Wolf, S.F., Robbins, P.D. & Lotze, M.T. (1994) Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor immunity to murine melanoma in vivo. Cancer Research, 54, 182-189.
29. Tahara, H. & Lotze, M.T. (1995) Antitumor effects of interleukin-12 (IL-12): applications for the immuotherapy and gene therapy of cancer. Gene Therapy, 2, 96-106.
30. Tahara, H., Zitvogel, L., Storkus, W.J., Zeh, H.J., IIIMcKinney, T.G., Schreiber, R.D., Guhler, U., Robbins, P.D. & Lotze, M.T. (1995) Effective eradication of established murine tumor with IL-12 gene therapy using a polycistronic retroviral vector. Journal of Immunology, 154, 6466-6474.
31. Trinchieri, G. (1995) Interleukin 12: a proinflammatory cytokine with immunoregulatory function that bridge innate resistance and antigen-specific adaptive immunity. Annual Review of Immunology, 13, 251-276.
32. Zhang, R., Minemura, K. & DeGroot, L.J. (1998) Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2. Endocrinology, 139, 601-608.
33. Zhang, R., Straus, F.H. & DeGroot, L.J. (1999) Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: Dissemination and cytotoxicity studies in a rat tumor model. Endocrinology, 140, 2152-2158.
34. Zitvogel, L., Tahara, H., Cai. Q., Storkus, W.J., Muller, G., Wolf, S.F., Gately, M., Robbins, P.D. & Lotze, M.E. (1994) Construction and characterization of retroviral vectors expression biologically active human interleukin-12. Human Gene Therapy, 5, 1493-1506.